Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TXN | P10599 | 1/20 | 0.70 |
| ▸ | NPC1 | O15118 | 2/20 | 0.67 |
| ▸ | RAB9A | P51151 | 2/20 | 0.67 |
| ▸ | TSHR | P16473 | 1/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.60 |
| ▸ | HPGD | P15428 | 5/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.58 |
| ▸ | FBP1 | P09467 | 3/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.58 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.58 |
| ▸ | DRD2 | P14416 | 1/20 | 0.58 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.58 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.58 |
| ▸ | DRD1 | P21728 | 1/20 | 0.58 |
| ▸ | MC5R | P33032 | 1/20 | 0.58 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.58 |
| ▸ | DRD3 | P35462 | 1/20 | 0.58 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL368458 | 0.98 | TXN (0.73) | TXNNPC1RAB9ATSHRALDH1A1 | |
| SCHEMBL21047920 | 0.84 | HSD17B10 (0.58) | TXNNPC1RAB9ATSHRALDH1A1 | |
| Hydrochloric Acid SCHEMBL4768521 | 0.84 | MEN1 (0.56) | TXNNPC1RAB9ATSHRALDH1A1 | |
| SCHEMBL8092636 | 0.83 | TXN (1.00) | TXNNPC1RAB9ATSHRALDH1A1 | |
| SCHEMBL366021 | 0.80 | NPC1 (1.00) | TXNNPC1RAB9ATSHRALDH1A1 | |
| SCHEMBL11536996 | 0.80 | CYP1A2 (0.63) | TXNNPC1RAB9ATSHRALDH1A1 | |
| SCHEMBL17500587 | 0.80 | HSD17B10 (0.53) | TXNNPC1RAB9ATSHRALDH1A1 | |
| SCHEMBL7055245 | 0.79 | ALDH1A1 (0.67) | TXNNPC1RAB9ATSHRALDH1A1 | |
| SCHEMBL10532201 | 0.78 | MAOB (0.53) | TXNNPC1RAB9ATSHRALDH1A1 | |
| SCHEMBL212831 | 0.78 | CYP1A2 (0.65) | TXNNPC1RAB9ATSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3592729-B1 | CATALYTIC C-X-BOND METATHESIS THROUGH ARYLATION | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2021-06-30 | — | — | EP | disclosed |
| EP-3592729-B1 | CATALYTIC C-X-BOND METATHESIS THROUGH ARYLATION | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2021-06-30 | — | — | EP | disclosed |
| US-20210130286-A1 | CATALYTIC C-X-BOND METATHESIS THROUGH ARYLATION | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2021-05-06 | — | — | US | disclosed |
| US-20210130286-A1 | CATALYTIC C-X-BOND METATHESIS THROUGH ARYLATION | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2021-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210130286-A1 | CATALYTIC C-X-BOND METATHESIS THROUGH ARYLATION | AOX1, TYR, CXXC4 | TXN 607/4885NPC1 2155/4885RAB9A 2781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.